View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Genitourinary Cancer News

SPONSORED CONTENT
Save
SPONSORED CONTENT
December 22, 2021
12 min read
Save

Experts in oncology help advise NASA on space radiation health standard for astronauts

Experts in oncology help advise NASA on space radiation health standard for astronauts

A select group of people who spend their day jobs fighting cancer — as surgical oncologists, radiation epidemiologists, or working in radiobiology and bionanotechnology — had a unique opportunity to lend their expertise to NASA.

SPONSORED CONTENT
December 08, 2021
2 min read
Save

City of Hope to acquire Cancer Treatment Centers of America for $390 million

City of Hope to acquire Cancer Treatment Centers of America for $390 million

City of Hope announced Wednesday that it has entered a definitive agreement to acquire Cancer Treatment Centers of America.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
December 06, 2021
2 min read
Save

Data ‘raised the red flag’ regarding COVID-19 pandemic’s impact on cancer diagnoses

Data ‘raised the red flag’ regarding COVID-19 pandemic’s impact on cancer diagnoses

Substantial reductions in procedures used to diagnose cancer and in new cancer diagnoses occurred across the U.S. because of the COVID-19 pandemic, according to a review of a large database of U.S. veterans published in Cancer.

SPONSORED CONTENT
December 02, 2021
2 min read
Save

Racial, ethnic minority populations underrepresented in precision oncology studies

Racial, ethnic minority populations underrepresented in precision oncology studies

Racial and ethnic minority populations remain underrepresented in many precision oncology trials relative to their cancer incidence in the U.S., according to study results published in JAMA Network Open.

SPONSORED CONTENT
December 01, 2021
2 min read
Save

Yoga improves quality of life, immune response in men with prostate cancer

Yoga improves quality of life, immune response in men with prostate cancer

Yoga therapy improved quality of life, immune responses and expression of inflammatory cytokines in men with newly diagnosed prostate cancer, according to results of a pilot randomized controlled trial.

SPONSORED CONTENT
November 24, 2021
2 min read
Save

Belzutifan active in von Hippel-Lindau disease-associated renal cell carcinoma

Belzutifan active in von Hippel-Lindau disease-associated renal cell carcinoma

Belzutifan demonstrated clinical efficacy among patients with von Hippel-Lindau disease-associated renal cell carcinoma, according to results of a phase 2 study published in The New England Journal of Medicine.

SPONSORED CONTENT
November 24, 2021
4 min read
Save

Should G-CSF be used to boost the immune system in patients with cancer and sepsis?

In certain settings.

SPONSORED CONTENT
November 24, 2021
12 min read
Save

Early recognition, prevention strategies could reduce costly burden of sepsis in patients with cancer

Early recognition, prevention strategies could reduce costly burden of sepsis in patients with cancer

Sepsis is a leading cause of preventable death across the globe, and patients with cancer have a 10 times higher likelihood of developing this life-threatening condition than those without cancer.

SPONSORED CONTENT
November 22, 2021
3 min read
Save

Despite progress, certain populations remain underrepresented in cancer clinical trials

Despite progress, certain populations remain underrepresented in cancer clinical trials

Although cancer clinical trial participation has increased among Black and Hispanic individuals, these populations — along with women and older adults — remained underrepresented, according to a study published in Cancer.

SPONSORED CONTENT
November 18, 2021
2 min read
Save

Most therapies tested in phase 3 cancer trials fail to confer meaningful survival benefit

Most therapies tested in phase 3 cancer trials fail to confer meaningful survival benefit

More than 80% of therapies tested in phase 3 oncology trials did not demonstrate clinically meaningful benefit in extending survival, according to results of a study published in JNCCN — Journal of the National Comprehensive Cancer Network.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails